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How A Pleural Effusion Workup Resulted in an AIDS-related Lymphoma
Diagnosis in an HIV Negative Patient
Saad Chaudhry MD, Lovepreet Singh MD, Shannon Wills PhD, Omokayode Osobamiro MD
Henry Ford Health System, Detroit, Michigan
Abstract
Primary effusion lymphoma, a subtype of Non-Hodgkin’s lymphoma, is
linked with HHV-8. This disease is associated with immunocompromised
patients such as those who have HIV, solid organ transplant carriers, or
chronic hepatitis C. Primary effusion lymphoma frequently commences in
the pleura, pericardium, and peritoneum.
A 77 year old middle eastern male with history of tobacco usage was
admitted for fatigue and hypotension. Chest X-ray revealed bilateral pleural
effusions. He had received a diagnostic and therapeutic thoracentesis.
Cytology revealed that it was positive for HHV-8, a diagnostic criteria for
primary effusion lymphoma. The patient was tested for HIV, HTLV, and
hepatitis B/C. The testing was negative. The patient later revealed that he
had Kaposi sarcoma a year prior to presentation on his right leg that was
removed by his dermatologist. After having multiple thoracenteses, the
patient later had a Pleurx catheter placed. Given the patient’s other heart
comorbidities, he was evaluated by oncology, and they had recommended a
more palliative approach.

AIDS-related Lymphoma
• Primary effusion lymphoma (PEL) is one of the least common of the AIDSrelated lymphomas, accounting for <1-4% of cases. However this can occur
in the absence if HIV infection and rarely has been seen following solid
organ transplantation.
• Malignant cells of PEL are monoclonal B cells that express surface CD-38
and contain genomic material from HHV-8
• PEL originates on serosal surfaces including the pleura (60-90%),
pericardium (up to 30%), peritoneum, joint spaces and rarely the meninges.
• Most affected patients present with a symptomatic serous effusion containing
high grade malignant lymphocytes. Patients usually present with symptoms
such as dyspnea (from pleural or pericardial effusion), abdominal distention
or joint swelling.

What are the types of Kaposi Sarcoma?
Epidemic Kaposi sarcoma (AIDS-related)
Seen in HIV patients and is an AIDS defining illness.
Most common cancers in HIV positive individuals
However this does not occur in every AIDS patient.
Classic Kaposi sarcoma (Mediterranean)
Seen in elderly Mediterranean, Middle Eastern and European men. HHV-8 infection is
more common in these areas therefore, more likely to affect a person with weakened
immune system.
Endemic Kaposi sarcoma (African)
It has been notes that not wearing shoes seems to increase the chances of endemic KS
possibly due to some lymphatic disorder connected to direct contact with soil.
Immunocompromised Kaposi sarcoma
More likely to occur in an individual with organ transplant and on immune suppression
medications.

Evaluation and Diagnosis
• DIAGNOSTIC WORKUP FOR PATIENT
• Chest X-Ray: Pulmonary edema or bilateral multifocal pneumonia with pleural effusions
• Thoracentesis: Ultrasound-guided thoracentesis with removal of 1100 mL of blood tinged
fluid from the left pleural cavity
• Cytology: malignant cells, primary effusion lymphoma.
• Next step Treatment: In our particular case the patent and family were offered evaluation
by two different oncologists but decision was made not to proceed with chemotherapy due
to multiple co-morbidities .
Diagnosis- KS diagnosed with skin biopsy from the center of the lesion.
• Other diagnostic tools in suspecting KS: Bronchoscopy, Endoscopy, and Colonoscopy.
(Bronchoscopy may be indicated in a person in whom you suspect KS who is having
respiratory difficulties. EGD and colonoscopies are other tools to use to help diagnose KS
located in the GI tract)
• Biopsy of skin lesion would be the first initial step to confirm the diagnosis of KS
• Fluid Examination: samples of the effusion are almost always positive for malignant cells
due to the unique liquid phase of growth of these tumors. The effusions are exudative and
often bloody.

Conclusion

This was a rather unusual diagnosis in an ailment that
typically is associated with HIV. The first line
treatment for primary effusion lymphoma is
cyclophosphamide, doxorubicin, etoposide,
vincristine, and prednisone along with HAART in
those who are HIV positive. The therapy is less clear
for those who are HIV negative due to being an
extremely rare patient population. There has been less
than 30 cases described in this subset population and
they have typically been elderly, Mediterranean males.
The key diagnostic criteria in diagnosing primary
effusion lymphoma is the expression of HHV-8 in the
malignant cells. Prognosis remains poor despite the
use of chemotherapy; median survival is 6 months.

Management
Highly active antiretroviral therapy (HAART) should be initiated
immediately in patients who have HIV once Kaposi sarcoma is diagnosed.
Other treatment options depends on the individual case. It may include :
• Radiation therapy which helps ease the symptoms and cosmetic aspect
of the disease.
• Surgical removal of small lesions on the skin surface or deeper lesions.
• Freezing (cryotherapy) of the skin lesions particularly on the face.
• Laser therapy (photocoagulation) to shrink skin lesions and ease pain
and bleeding of deeper lesions.
• Topical applications such as retinoids to slow tumor growth.
• Injectable solutions (chemotherapy and biological therapy) such as
anthracyclines, interferons, taxanes and vinca alkaloids.

Photos

Figure 1. Brown-Red or purple nodules or blotches on the skin slightly raised.
Figure 2: Primary effusion lymphoma, Wright-Giemsa stained smear of pleural fluid.
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